Search results
Andrew SP Sharp
Job title: Professor of Cardiology
Author
Added:
1 year ago
Source:
Radcliffe Cardiology
AUTHOR: Jordan Rance; Special Editor: Greg GuilloryAmerican Heart Association, 18 November 2024 – Dr Daniel Judge announced the findings from the ATTRibute-CM OLE study (Eidos Therapeutics; NCT03860935), an open-label extension of the Phase 3 ATTRibute-CM trial. The study aims to evaluate the long-term efficacy and safety of acoramidis in treating transthyretin amyloid cardiomyopathy (ATTR-CM)…
View more
Mark Yan Yee Chan
Research Area(s) / Expertise:
Author
Zahid Khan
Author
Added:
4 months ago
Source:
Radcliffe CVRM
Patients with chronic kidney disease (CKD) are particularly vulnerable to complications from influenza. A prespecified subgroup analysis of the DANFLU-2 trial has found that a high-dose inactivated influenza vaccine (HD-IIV) provides a greater relative benefit against severe clinical outcomes compared to a standard-dose vaccine (SD-IIV) in this high-risk population.¹MethodologyDANFLU-2 was a…
View more
Robert Hauser
Author
Wayne Batchelor
Author
Amod Amritphale
Research Area(s) / Expertise:
Job title: Interventional Cardiologist and Director of Cardiovascular Research
Author
Calvin WL Chin
Author
Francesco Maisano
Research Area(s) / Expertise:
Job title: Head of Cardiac Surgery, Director of the Valve Center
Author